Problematic Reliance on Generative AI in an Anxious Young Adult: Case Report
Generative Artificial Intelligence (AI) tools are increasingly integrated into daily life, offering cognitive support across domains such as writing, decision-making, and social interpretation. While beneficial, excessive reliance may contribute to diminished confidence in one’s own thinking. This report describes a woman in her mid-20s with Generalized Anxiety Disorder and Major Depressive Disorder who developed a pattern of functional dependence on generative AI tools- specifically ChatGPT. She historically had strong social, academic and occupational functioning. Psychiatric consultation did not suggest the presence of a personality disorder, and although she was a high-achieving individual, clinically significant perfectionistic traits were not evident. Despite this, she increasingly relied on AI for routine cognitive and interpersonal tasks including composing emails, interpreting social interactions, predicting the future and making decisions and felt increasingly uncomfortable completing such tasks independently. This case highlights the potential danger of generative AI tools in reassurance seeking behavior and how it might compound anxiety. These behaviors were observed across both professional and personal contexts, suggesting that AI use was not limited to task-specific assistance but reflected a generalized strategy for managing uncertainty and self-doubt. This behavioral pattern is characterized in this case by cognitive offloading, reduced confidence in independent judgment, and reinforcement of externalized thinking processes. This led to the subjective belief of declining skill and compromised functional autonomy. The Interaction of Person-Affect-Cognition-Execution (I-PACE) model was used to describe this pattern of behavior. While repeatedly turning to a family member or friend for validation and reassurance might lead to interpersonal fatigue, AI tools have no such limits and are infinitely accessible. This might ultimately worsen a patient’s ability to tolerate uncertainty. Given the ubiquity of AI tools and the prevalence of anxiety disorders, clinicians may need to be aware of the role AI tools potentially play in reassurance seeking and thus perpetuation of anxiety.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/b5b1c680b8f330c90144ec99278fd88a" />
Transcutaneous auricular vagus nerve stimulation targets the brain-gut axis to treat functional dyspepsia: a scoping review of clinical evidence and mechanistic research
Investigation of psychiatric symptoms, dissociative experiences, and childhood trauma in allergic rhinitis, and evaluation of the clinical relationship between these factors
Association between perceived school climate and employment anxiety among medical undergraduates: the mediating role of intentional self-regulation and the moderating role of perceived employability
Emotion regulation difficulties and experiential avoidance in adolescents with non-suicidal self-injury: a latent profile and moderation analysis
STAT+: Definium’s LSD therapy eased anxiety in second large trial
Definium Therapeutics said Monday that its LSD therapy helped patients with anxiety in a second late-stage trial, setting up the company to seek the first approval of a psychedelic drug for anxiety.
In the 12-week trial, patients taking a 100-microgram dose of the drug, called DT120, experienced a 9.8-point drop on a test called the Hamilton Anxiety Rating Scale, while those on placebo experienced a 4.7-point drop. The difference of 5.1 points is similar to what was seen in Definium’s first late-stage anxiety study and larger than what’s been observed with many other anxiety therapies, though it’s difficult to compare results across studies.
Definium is among the first wave of biotechs nearing regulatory approval for psychedelic therapies, a class of treatments that may be especially attractive to patients since they appear to exert rapid benefits. (In the latest trial, Definium said patients experienced changes as early as the second day after dosing.) In contrast, the effects of traditional options like antidepressants take weeks to kick in.
Screening and Monitoring of Mental Health in Educational Settings: Programme for Detection, Psychoeducation and Self-help
Interventions: Other: program for the detection, referral, and psychoeducation in adolescents
Sponsors: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Hospital Universitario Rey Juan Carlos; Hospital Universitario Infanta Elena; Universidad Carlos III de Madrid; Centro de Investigación Biomédica en Red de Salud Mental
Completed
Recovery-phase symptoms after COVID-19 infection and anxiety levels among college students
Renaclic for Chronic Kidney Disease Self-Management: Formative User-Centered Co-Design Study
Background: Chronic kidney disease (CKD) affects over 850 million individuals worldwide and requires sustained patient education, shared decision-making, and self-management support. Digital health platforms may facilitate these needs; however, many lack comprehensive, user-centered design and fail to address practical and psychosocial patient concerns. Objective: This study aimed to describe the formative co-design of Renaclic, a digital platform developed with patients and health care professionals (HCPs) to support CKD education and self-management in the French health care context. Methods: A three-stage user-centered design (UCD) study was conducted between April and August 2021. Stage 1 included benchmarking of 10 French-language CKD platforms and semistructured interviews with 8 stakeholders (3 HCPs: 1 nephrologist, 1 general practitioner, 1 nurse; 5 patients: 2 novice and 3 expert users). Stage 2 consisted of two virtual co-design focus groups incorporating card-sorting and interface design activities. Stage 3 translated identified needs into structured content categories and a low-fidelity prototype. Qualitative data were analyzed thematically. Results: Benchmarking revealed fragmented educational content, limited practical guidance on home dialysis logistics, insufficient coverage of lifestyle and psychosocial concerns, and minimal interactive features. Interviews identified five main themes: need for reliable centralized information, anxiety during care transitions, demand for practical lifestyle guidance, importance of reassuring language, and value of moderated peer exchange. More than 30 thematic content items were generated and organized through card-sorting into five consolidated content categories that structured the platform’s information architecture. Co-design sessions informed mobile accessibility, simplified navigation pathways, and integration of educational, symptom-tracking, and community-oriented functionalities. Conclusions: This formative study demonstrates how participatory UCD with diverse CKD stakeholders can generate a structured, context-sensitive digital platform framework. Renaclic provides a replicable model for early-stage co-design of digital health interventions in chronic disease management. Future research will evaluate usability, engagement, and implementation in real-world settings.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/ba7e69d2448a2fd5498156332504853e" />

